Convenient Synthesis of N-Tosyl-2-(difluoromethyl)aziridine and Its Application to the Preparation of Difluoromethyl-β-tryptamine Analogues

Fumihiro Kurosato; Takuya Ishikawa; Yasunori Yamada; Takeshi Hanamoto

doi:10.1055/s-0034-1381008

Synlett, Table of Contents

Synlett 2015; 26(13): 1827-1830
DOI: 10.1055/s-0034-1381008

letter

Convenient Synthesis of N-Tosyl-2-(difluoromethyl)aziridine and Its Application to the Preparation of Difluoromethyl-β-tryptamine Analogues

Fumihiro Kurosato

Department of Chemistry and Applied Chemistry, Graduate School of Science and Engineering, Saga University, Honjyo-machi 1, Saga 840-8502, Japan Email: hanamoto@cc.saga-u.ac.jp

,

Takuya Ishikawa

Department of Chemistry and Applied Chemistry, Graduate School of Science and Engineering, Saga University, Honjyo-machi 1, Saga 840-8502, Japan Email: hanamoto@cc.saga-u.ac.jp

,

Yasunori Yamada

Department of Chemistry and Applied Chemistry, Graduate School of Science and Engineering, Saga University, Honjyo-machi 1, Saga 840-8502, Japan Email: hanamoto@cc.saga-u.ac.jp

,

Takeshi Hanamoto*

Department of Chemistry and Applied Chemistry, Graduate School of Science and Engineering, Saga University, Honjyo-machi 1, Saga 840-8502, Japan Email: hanamoto@cc.saga-u.ac.jp

› Author Affiliations

Abstract

All articles of this category

Abstract

N-Tosyl-2-(difluoromethyl)aziridine was easily prepared from p-toluenesulfonamide (TsNH₂) and β-(difluoromethyl) vinyl sulfonium salt in excellent yield. The reaction of the aziridine and a wide range of indoles in the presence of Et₂Zn proceeded smoothly to give the corresponding difluoromethyl-β-tryptamine analogues in good to excellent yields and with excellent regioselectivity.

Key words

organofluorine - aziridine - ring-opening - indole - tryptamine

Full Text

References

References and Notes

1a Ha H.-J, Jung J.-H, Lee WK. Asian J. Org. Chem. 2014; 3: 1020
1b Jung N, Bräse S. Angew. Chem. Int. Ed. 2012; 51: 5538
1c Florio S, Luisi R. Chem Rev. 2010; 110: 5128
1d Singh GS, D’hooghe M, De Kimpe N. Chem. Rev. 2007; 107: 2080
1e Watson ID. G, Yu L, Yudin AK. Acc. Chem. Res. 2006; 39: 194

2a Ojima I. J. Org. Chem. 2013; 78: 6358
2b Kirk KL. Org. Process Res. Dev. 2008; 12: 305
2c Purser S, Moore PR, Swallow S, Gouverneur V. Chem. Soc. Rev. 2008; 37: 320
2d Müller K, Faeh C, Diederich F. Science 2007; 317: 1881
2e Isanbor C, O’Hagan D. J. Fluorine Chem. 2006; 127: 303

For the works of our group, see:

3a Yoshiki M, Ishibashi R, Yamada Y, Hanamoto T. Org. Lett. 2014; 16: 5509
3b Hirotaki K, Yamada Y, Hanamoto T. Asian J. Org. Chem. 2014; 3: 285
3c Takehiro Y, Hirotaki K, Takeshita C, Furuno H, Hanamoto T. Tetrahedron 2013; 69: 7448
3d Maeda R, Ishibashi R, Kamaishi R, Hirotaki K, Furuno H, Hanamoto T. Org. Lett. 2011; 13: 6240

For the works of other groups, see:

4a Dolfen J, Kenis S, Van Hecke K, De Kimpe N, D’hooghe M. Chem. Eur. J. 2014; 20: 10650
4b Waki M, Katagiri T, Matsuno K, Miyachi H. Tetrahedron Lett. 2014; 55: 6915
4c Moens M, De Kimpe N, D’hooghe M. J. Org. Chem. 2014; 79: 5558
4d Edman K, Ahlgren R, Bengtsson M, Bladh H, Bäckström S, Dahmén J, Henriksson K, Hillertz P, Hulikal V, Jerre A, Kinchin L, Káse C, Lepistö M, Mile I, Nilsson S, Smailagic A, Taylor J, Tjörnebo A, Wissler L, Hansson T. Bioorg. Med. Chem. Lett. 2014; 24: 2571
4e Kuzmich D, Bentzien J, Betageri R, DiSalvo D, Fadra-Khan T, Harcken C, Kukulka A, Nabozny G, Nelson R, Pack E, Souza D, Thomson D. Bioorg. Med. Chem. Lett. 2013; 23: 6640
4f Kenis S, D’hooghe M, Verniest G, Reybroeck M, Anh Dang Thi T, Pham The C, Thi Pham T, Törnroos KW, Van Tuyen N, De Kimpe N. Chem. Eur. J. 2013; 19: 5966
4g Rassukana YV, Bezgubenko LV, Onys’ko PP, Synytsya AD. J. Fluorine Chem. 2013; 148: 14
4h Yang Y, Huang Y, Qing F.-L. Tetrahedron Lett. 2013; 54: 3826
4i Kenis S, D’hooghe M, Verniest G, Duc Nguyen V, Anh Dang Thi T, Van Nguyen T, De Kimpe N. Org. Biomol. Chem. 2011; 9: 7217
4j Rinaudo G, Narizuka S, Askari N, Crousse B, Bonnet-Delpon D. Tetrahedron Lett. 2006; 47: 2065
4k Yamauchi Y, Kawate T, Katagiri T, Uneyama K. Tetrahedron 2003; 59: 9839
4l Yamauchi Y, Kawate T, Itahashi H, Katagiri T, Uneyama K. Tetrahedron Lett. 2003; 44: 6319
4m Akiyama T, Ogi S, Fuchibe K. Tetrahedron Lett. 2003; 44: 4011
4n Volonterio A, Bravo P, Panzeri W, Pesenti C, Zenda M. Eur. J. Org. Chem. 2002; 3336
4o Crousse B, Narizuka S, Bonnet-Delpon D, Bégué J.-P. Synlett 2001; 679
4p Katagiri T, Takahashi M, Fujiwara Y, Ihara H, Kenji U. J. Org. Chem. 1999; 64: 7323
4q Katagiri T, Ihara H, Takahashi M, Kashino S, Furuhashi K, Uneyama K. Tetrahedron: Asymmetry 1997; 8: 2933
4r Tanaka K, Kagatani S, Ohsuga M, Mitsuhashi K. Bull. Chem. Soc. Jpn. 1994; 67: 589
4s Quinze K, Laureny A, Mison P. J. Fluorine Chem. 1989; 44: 233
4t Tanaka K, Ohsuga M, Sugimoto Y, Okafuji Y, Mitsuhashi K. J. Fluorine Chem. 1988; 39: 39

5a Meanwell NA. J. Med. Chem. 2011; 54: 2529
5b Erickson JA, McLoughlin JI. J. Org. Chem. 1995; 60: 1626

6 Ishikawa T, Kasai N, Yamada Y, Hanamoto T. Tetrahedron 2015; 71: 1254

7a Kasai N, Maeda R, Furuno H, Hanamoto T. Synthesis 2012; 44: 3489
7b Maeda R, Ooyama K, Anno R, Shiosaki M, Azema T, Hanamoto T. Org. Lett. 2010; 12: 2548

To the best of our knowledge, there are only two reports concerning CF₂H-aziridines. See:

8a Schweitzer-Chaput B, Keita M, Milcent T, Ongeri S, Crousse B. Tetrahedron 2012; 68: 7028
8b Mae M, Matsuura M, Amii H, Uneyama K. Tetrahedron Lett. 2002; 43: 2069

9 Experimental Procedure for 1a: A-100 mL round-bottom flask equipped with a magnetic stir bar was charged with K₂CO₃ (2.11 g, 15.0 mmol) and p-toluenesulfonamide (865.0 mg, 5.0 mmol) in EtOAc (10 mL). To this suspension was added β-(difluoromethyl)vinyl diphenyl sulfonium triflate (2.21 g, 5.25 mmol; see ref. 6) and the resulting suspension was stirred at r.t. for 1 h. The reaction was carefully quenched with aq NH₄Cl solution (10 mL) and extracted with hexane–EtOAc (3:1). The extraction was repeated twice. The combined organic layers were dried over Na₂SO₄ and concentrated under reduced pressure. The oily residue was purified by silica gel column chromatography (hexane–Et₂O, 1:1) to give the desired product 1a as white solid (1.23 g, 98%); mp 48.6–48.9 °C. IR (ATR): 3057, 1599, 1319, 1161, 1098, 1051, 992, 974, 878, 801, 727, 662 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 7.48 (d, J = 8.2 Hz, 2 H), 7.37 (d, J = 8.2 Hz, 2 H), 5.57 (td, J = 55.1, 4.1 Hz, 1 H), 3.05–3.20 (m, 1 H), 2.77 (d, J = 7.0 Hz, 1 H), 2.47 (s, 3 H), 2.42 (d, J = 4.1 Hz, 1 H). ¹³C NMR (101 MHz, CDCl₃): δ = 145.3, 134.0, 129.9, 128.1, 113.1 (t, J = 241.3 Hz), 37.9 (t, J = 32.7 Hz), 28.7 (t, J = 3.9 Hz), 21.7. ¹⁹F NMR (376 MHz, CDCl₃): δ = –120.9 (ddd, J = 296.8, 55.1, 7.1 Hz), –124.4 (ddd, J = 296.8, 55.1, 7.1 Hz). GC–MS (EI, 70 eV): m/z = 247 (11) [M⁺], 155 (50), 92 (58), 91 (100), 89 (8), 65 (26), 63 (7), 51 (5). Anal. Calcd for C₁₀H₁₁F₂NO₂S: C, 48.57; H, 4.48; N, 5.66. Found: C, 48.58; H, 4.40; N, 5.65.
10 Schirlin D, Gerhart F, Hornsperger JM, Hamon M, Jung MJ. J. Med. Chem. 1988; 31: 30
11 Experimental Procedure for 3a: A 25-mL two-neck flask equipped with a magnetic stir bar, a stopcock and, a three-way stopcock was charged with o-xylene (1 mL) under argon. To this solution were successively added indole 2a (37.0 mg, 0.32 mmol), 2-CF₂H-N-Ts-aziridine 1a (60.1 mg, 0.24 mmol), and Et₂Zn (1.06 M in hexane solution, 0.30 mL). After the mixture was stirred for 5 min at r.t., the flask was immersed in a preheated (150 °C) oil bath and stirred at this temperature for 1 h until the complete consumption of 1a (checked by TLC and GC–MS). After the reaction mixture was cooled to r.t., to the mixture was added a sat. aq solution of NH₄Cl (1 mL), and the resulting mixture was extracted with EtOAc (2 mL) three times. The combined organic fractions were dried over Na₂SO₄. The residue was purified by chromatography on a silica gel column (hexane–EtOAc = 10:1, 3:1, then 1:1 as an eluent) to give 3a (96%, 84.4 mg) as a pale pink solid; mp 152.0–153.0 °C. IR (ATR): 1597, 1319, 1159, 1087, 1066, 1038, 747, 667, 572, 549, 524, 507 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 7.98 (s, 1 H), 7.36 (d, J = 7.1 Hz, 2 H), 7.26–7.31 (m, 2 H), 7.17 (t, J = 7.5 Hz, 1 H), 7.02 (t, J = 7.2 Hz, 1 H), 6.92 (d, J = 8.6 Hz, 3 H), 5.94 (t, J = 55.7 Hz, 1 H), 4.79 (d, J = 6.6 Hz, 1 H), 3.69–3.73 (m, 1 H), 3.14 (dd, J = 14.8, 4.9 Hz, 1 H), 2.90 (dd, J = 14.8, 8.8 Hz, 1 H), 2.28 (s, 3 H). ¹³C NMR (101 MHz, CDCl₃): δ = 143.3, 136.3, 135.8, 129.2, 126.7, 126.6, 123.3, 122.3, 119.8, 118.2, 115.0 (t, J = 246.1 Hz), 111.2, 108.9, 54.9 (t, J = 25.7 Hz), 23.3, 21.5. ¹⁹F NMR (376 MHz, CDCl₃): δ = –128.4 (ddd, J = 282.0, 55.7, 9.5 Hz), –134.1 (ddd, J = 282.0, 55.7, 16.3 Hz). GC–MS (EI, 70 eV): m/z = 364 (7) [M⁺], 193 (2), 155 (2), 130 (100), 103 (4), 91 (7), 77 (5), 65 (2). HRMS (ESL–TOF): m/z [M + Na]⁺ calcd for C₁₈H₁₈F₂N₂O₂SNa: 387.0955; found: 387.0950.
12 CCDC 1059066 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, or by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44(1223)336033.

Supplementary Material

Supporting Information